SOLUTIONS FOR
PHARMACEUTICAL
MANUFACTURERS
Maximize the power of real-world evidence and analytic insights to demonstrate the value of your medicines.
Value-based care doesn’t exclude drugs. RxAnte solutions prepare pharmaceutical manufacturers for a world where demonstrating real-world outcomes are essential and performance-based contracts are a part of product differentiation.
Powered by our industry-leading health analytics and cloud-based software, our drug value solutions bridge the information gap between pharma and health plans. Here’s how:
Evidence Development
Partner with health plans to generate real-world evidence on member populations and uncover valuable opportunities for your drugs.
Learn More
Value-Based Contract (VBC) Enablement
Let RxAnte arm you and your health plan partners with data and recommendations to design innovative value-based contracts, facilitated by our client services.
Learn More
VBC Scorecard
We believe VBC performance should be transparent in real-time to both pharmaceutical manufacturers and health plans. Our capabilities make successful VBCs possible.
Learn MoreEvidence Development
Uncover outcomes improvement opportunities alongside your health plan partners.
Licensing anonymized, aggregated data sets has been the standard approach to measuring real-world impact for years. The RxAnte evidence development solution changes that by making evidence-focused partnerships between pharmaceutical manufacturers and health plans possible. Including analysis on:
- Disease prevalence
- Health outcomes
- Budget impact
- Competitive analysis
- Prospective outcomes and utilization analyses
- VBC recommendation
The first step in many eventual value-based partnerships, evidence development rapidly answers the questions that both you and your health plan partners are asking: how are your drugs currently impacting the health and financial outcomes of plans’ member populations, or how might they in the future? Let’s find out together.
Contact us to learn more about how we assess your drug’s performance in the real world.
Value-Based Contract (VBC) Enablement
We make successful VBCs happen.
Industry-wide cost pressures and value-based models of care are changing healthcare, but for drugs, the path forward is challenging. A lack of tech infrastructure, asymmetrical access to drug performance data, and achieving consensus with all parties are a few key obstacles for pharma. Our VBC enablement solution helps tear down these barriers by delivering the transparent analytics platform and consultative services needed to design a value-based contract containing performance measures amenable to both pharmaceutical manufacturers and health plans, minimizing the financial and execution risk that accompanies VBCs today.
Contact us to understand the accelerators, tools, and services we bring to VBC Enablement.
VBC Scorecard
Don’t step away from your active VBCs – watch them perform.
Unlike traditional pharmaceutical agreements in which the financial details remain static during the course of the contract, VBCs are constantly evolving. The ongoing monitoring and management of their performance is vital to the satisfaction of health plan and manufacturer and key to achieving desired health outcomes.
Our VBC scorecard enables all of this by delivering a transparent, real-time performance monitoring platform that is configured to the metrics agreed upon in each VBC. We also apply our industry-leading predictive analytics models to identify adherence improvement opportunities to maximize the health and financial performance of the contract.
Contact us to see a demonstration of our VBC Scorecard and how it can work for your products.
Article
BioCentury: Risky Business – How Amgen is approaching Repatha access post FOURIER data
Check It Out
Request More Info
Think RxAnte might be right for your organization? Let’s get in touch.
Pharmaceutical Resources
More Resources01.11.16
Private: Best Practices from the Front Lines: Engaging Providers to Improve Medication Use
Whitepaper
Evidence shows that providers are vital to improving their patients adherence levels. But how can they overcome administrative and logistical barriers to do this? Read our white paper to find out.
11.06.14
JAMA Viewpoint: Designing Smarter Pay-for-Performance Programs
Whitepaper
Pay-for-performance has its challenges, including finding the right incentives and identifying the right measures for programs. Could better targeted programs be the answer? Read this co-authored article for more.
Not Just for Pharma
For Health Plans
By collaborating with RxAnte, our health plan clients find clarity and improvement in long-standing challenges like poor medication adherence and unclear drug value.
Tell Me More
For Providers
RxAnte offers solutions specific to the needs of health care providers, including an innovative platform that monitors, prioritizes, and informs patient outreach to ensure proper patient medication use.
Tell Me More
Our Interventions
RxAnte provides payers and providers with access to tools and resources to help improve medication use, optimize health outcomes, and reach organizational quality and financial goals.
Tell Me More